Bajaj Healthcare Ltd

Bajaj Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bajaj Healthcare Ltd

₹ 307 -0.57%
26 May - close price
bajajhealth.com BSE: 539872 NSE : BAJAJHCARE
About

Established in the year 1993, Bajaj Healthcare Ltd is an estalished player in the Indian Pharmacuetical Industry and fastest growing mid-cap pharmaceutical companies in India.[1]

It is a bulk drug manufacturer manufacturing and supply of various Active Pharmaceutical Ingredients (API's), Amino acids and Nutritional supplements for Pharmaceuticals, Neutraceuticals, Food industries. [2]

Key Points

Product Portfolio
The Co. is into manufacturing and supply of API's, Intermediates, Formulations and Impurities. [1]
With 6 API manufacturing facilities spread across different states, API contributes around 90% to the overall revenue mix. It has a strong presence in more than 50 countries through exports of API's with an aggregate manufacturing capacity of 730 MT per month. [2]

Website BSE NSE
  • Market Cap ₹ 847 Cr.
  • Current Price ₹ 307
  • High / Low ₹ 458 / 257
  • Stock P/E 14.9
  • Book Value ₹ 129
  • Dividend Yield 0.49 %
  • ROCE 20.0 %
  • ROE 24.3 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has delivered good profit growth of 55.5% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 27.0%

Cons

  • Contingent liabilities of Rs.64,588 Cr.
  • Company might be capitalizing the interest cost
  • Debtor days have increased from 80.6 to 99.0 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
118 140 207 178 132 186 151 168 176 172 201 142
99 114 174 134 98 152 122 137 150 146 168 113
Operating Profit 20 25 32 44 35 33 29 31 25 26 33 29
OPM % 17% 18% 16% 25% 26% 18% 19% 18% 14% 15% 17% 20%
3 1 2 2 2 1 0 0 0 1 0 0
Interest 1 2 2 2 2 3 2 3 4 4 5 7
Depreciation 3 4 4 4 4 4 4 5 4 7 6 7
Profit before tax 18 20 28 40 30 27 22 23 17 16 22 15
Tax % 30% 25% 29% 34% 30% 30% 22% 25% -3% 26% 26% 27%
Net Profit 13 15 20 26 21 19 17 17 17 12 16 11
EPS in Rs 4.55 5.54 7.29 9.57 7.71 6.96 6.25 6.32 6.33 4.36 5.93 4.00
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
120 142 171 205 218 223 231 327 370 410 657 680 691
106 130 158 186 189 193 200 288 327 362 521 561 578
Operating Profit 13 11 13 19 29 30 31 39 43 48 136 119 113
OPM % 11% 8% 7% 9% 13% 14% 13% 12% 12% 12% 21% 17% 16%
1 0 0 0 0 0 2 2 1 7 7 1 1
Interest 4 5 6 7 8 8 8 8 8 7 8 13 20
Depreciation 5 6 8 9 9 9 11 11 11 12 16 18 24
Profit before tax 6 1 -2 3 12 14 14 23 24 36 119 90 70
Tax % 29% 38% 31% 40% 37% 39% 43% 33% 33% 30% 30% 20%
Net Profit 4 1 -1 2 8 8 8 15 16 25 83 71 57
EPS in Rs 4.44 0.72 -1.18 2.19 8.34 3.04 2.83 5.50 5.91 9.14 30.11 25.87 20.62
Dividend Payout % -0% -0% -0% -0% -0% -0% -0% 5% -0% -0% 5% 6%
Compounded Sales Growth
10 Years: 17%
5 Years: 24%
3 Years: 22%
TTM: 9%
Compounded Profit Growth
10 Years: 60%
5 Years: 56%
3 Years: 63%
TTM: -24%
Stock Price CAGR
10 Years: %
5 Years: 23%
3 Years: 34%
1 Year: -2%
Return on Equity
10 Years: 20%
5 Years: 24%
3 Years: 27%
Last Year: 24%

Balance Sheet

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
4 4 4 4 4 7 7 7 7 14 14 14 14
Reserves 26 27 26 28 78 82 92 107 122 164 245 315 343
47 61 70 70 69 81 75 87 81 91 181 257 335
32 32 33 45 40 39 45 68 57 74 86 136 134
Total Liabilities 107 121 131 145 189 209 219 268 267 343 526 721 826
34 46 54 56 108 130 128 127 128 162 208 270 262
CWIP 15 13 5 3 1 1 0 2 1 5 57 52 93
Investments -0 -0 -0 -0 -0 -0 -0 -0 -0 5 -0 -0 -0
58 63 72 87 79 78 91 140 137 170 260 399 470
Total Assets 107 121 131 145 189 209 219 268 267 343 526 721 826

Cash Flows

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
5 9 14 17 28 25 22 17 25 21 44 1
-17 -15 -8 -9 -17 -31 -8 -12 -13 -28 -109 -75
11 6 -7 -8 -11 5 -13 2 -13 3 75 62
Net Cash Flow -1 0 -0 1 -0 -0 0 7 -0 -4 10 -12

Ratios

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 79 90 95 98 86 70 83 90 77 88 55 99
Inventory Days 113 58 43 51 50 56 45 57 45 54 94 143
Days Payable 122 60 51 68 63 46 51 74 45 80 67 94
Cash Conversion Cycle 70 87 87 81 73 80 78 73 77 62 82 148
Working Capital Days 66 62 71 62 52 52 58 61 66 76 90 142
ROCE % 15% 7% 5% 10% 16% 13% 13% 16% 16% 18% 36% 20%

Shareholding Pattern

Numbers in percentages

3 Recently
Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
67.26 67.26 67.26 67.26 67.26 67.26 67.26 67.26 67.30 67.30 67.42 67.49
0.00 0.00 0.00 0.00 0.00 0.34 0.32 0.38 0.32 0.09 0.94 0.78
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.34 0.34
32.74 32.74 32.74 32.74 32.74 32.39 32.42 32.36 32.38 32.62 31.30 31.38

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls

  • Jun 2022
    Transcript
    Notes
    PPT
  • Aug 2020
    Transcript
    Notes
    PPT